NPHC — Nutra Pharma Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $7.10m
- $16.21m
- $0.59m
Annual income statement for Nutra Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.104 | 0.052 | 0.098 | 0.438 | 0.595 |
| Cost of Revenue | |||||
| Gross Profit | 0.035 | 0.015 | 0.008 | 0.249 | 0.396 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.24 | -0.61 | 2.51 | 2.5 | 1.47 |
| Operating Profit | -1.14 | 0.662 | -2.41 | -2.06 | -0.879 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.59 | -0.769 | -13.1 | 8.18 | -1.39 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.59 | -0.769 | -13.1 | 8.18 | -1.39 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.59 | -0.769 | -13.1 | 8.18 | -1.39 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.59 | -0.769 | -13.1 | 8.18 | -1.39 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0 | -0.002 | 0 | -0 |